Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Personalised human albumin in patients with cirrhosis and ascites: design and rationale for the ALB-TRIAL - a randomised clinical biomarker validation trial.
Torp N, Israelsen M, Coenraad M, Papp M, Shawcross D, Korenjak M, Angeli P, Laleman W, Juanola A, Gines P, Trebicka J, Krag A; MICROB-PREDICT Consortium. Torp N, et al. BMJ Open. 2024 Feb 14;14(2):e079309. doi: 10.1136/bmjopen-2023-079309. BMJ Open. 2024. PMID: 38355195 Free PMC article. Clinical Trial.
Sphingosine-1-phosphate receptor 3 regulates the transendothelial transport of high-density lipoproteins and low-density lipoproteins in opposite ways.
Velagapudi S, Wang D, Poti F, Feuerborn R, Robert J, Schlumpf E, Yalcinkaya M, Panteloglou G, Potapenko A, Simoni M, Rohrer L, Nofer JR, von Eckardstein A. Velagapudi S, et al. Among authors: feuerborn r. Cardiovasc Res. 2024 Apr 30;120(5):476-489. doi: 10.1093/cvr/cvad183. Cardiovasc Res. 2024. PMID: 38109696 Free PMC article.
Apolipoprotein M and Sphingosine-1-Phosphate Receptor 1 Promote the Transendothelial Transport of High-Density Lipoprotein.
Velagapudi S, Rohrer L, Poti F, Feuerborn R, Perisa D, Wang D, Panteloglou G, Potapenko A, Yalcinkaya M, Hülsmeier AJ, Hesse B, Lukasz A, Liu M, Parks JS, Christoffersen C, Stoffel M, Simoni M, Nofer JR, von Eckardstein A. Velagapudi S, et al. Among authors: feuerborn r. Arterioscler Thromb Vasc Biol. 2021 Oct;41(10):e468-e479. doi: 10.1161/ATVBAHA.121.316725. Epub 2021 Aug 19. Arterioscler Thromb Vasc Biol. 2021. PMID: 34407633 Free PMC article.
Apolipoprotein E interrupts interleukin-1beta signaling in vascular smooth muscle cells.
Kawamura A, Baitsch D, Telgmann R, Feuerborn R, Weissen-Plenz G, Hagedorn C, Saku K, Brand-Herrmann SM, von Eckardstein A, Assmann G, Nofer JR. Kawamura A, et al. Among authors: feuerborn r. Arterioscler Thromb Vasc Biol. 2007 Jul;27(7):1610-7. doi: 10.1161/ATVBAHA.106.129957. Epub 2007 May 17. Arterioscler Thromb Vasc Biol. 2007. PMID: 17510469
Apolipoprotein A-I activates Cdc42 signaling through the ABCA1 transporter.
Nofer JR, Remaley AT, Feuerborn R, Wolinnska I, Engel T, von Eckardstein A, Assmann G. Nofer JR, et al. Among authors: feuerborn r. J Lipid Res. 2006 Apr;47(4):794-803. doi: 10.1194/jlr.M500502-JLR200. Epub 2006 Jan 28. J Lipid Res. 2006. PMID: 16443932 Free article.
Involvement of Cdc42 signaling in apoA-I-induced cholesterol efflux.
Nofer JR, Feuerborn R, Levkau B, Sokoll A, Seedorf U, Assmann G. Nofer JR, et al. Among authors: feuerborn r. J Biol Chem. 2003 Dec 26;278(52):53055-62. doi: 10.1074/jbc.M305673200. Epub 2003 Oct 16. J Biol Chem. 2003. PMID: 14563854 Free article.